Collegium Pharmaceutical (COLL) Cash from Operations (2016 - 2026)
Collegium Pharmaceutical has reported Cash from Operations over the past 10 years, most recently at 123048000.0 for Q4 2025.
- For Q4 2025, Cash from Operations rose 45.37% year-over-year to 123048000.0; the TTM value through Dec 2025 reached 329323000.0, up 60.66%, while the annual FY2025 figure was 329323000.0, 60.66% up from the prior year.
- Cash from Operations for Q4 2025 was 123048000.0 at Collegium Pharmaceutical, up from 78438000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 123048000.0 in Q4 2025 and troughed at 25315000.0 in Q1 2022.
- A 5-year average of 51841950.0 and a median of 58667500.0 in 2024 define the central range for Cash from Operations.
- Biggest five-year swings in Cash from Operations: crashed 223.07% in 2022 and later skyrocketed 971.63% in 2025.
- Year by year, Cash from Operations stood at 36198000.0 in 2021, then surged by 83.23% to 66325000.0 in 2022, then increased by 10.57% to 73338000.0 in 2023, then rose by 15.42% to 84644000.0 in 2024, then soared by 45.37% to 123048000.0 in 2025.
- Business Quant data shows Cash from Operations for COLL at 123048000.0 in Q4 2025, 78438000.0 in Q3 2025, and 72439000.0 in Q2 2025.